Cargando…
Analysis of microRNA Expression Profiles Induced by Yiqifumai Injection in Rats with Chronic Heart Failure
Background: Yiqifumai Injection (YQFM) is clinically used to treat various cardiovascular diseases including chronic heart failure (CHF). The efficacy of YQFM for treating heart failure has been suggested, but the mechanism of action for pharmacological effects of YQFM is unclear. Methods: Echocardi...
Autores principales: | Zhao, Yu, Li, Yunfei, Tong, Ling, Liang, Xinying, Zhang, Han, Li, Lan, Fan, Guanwei, Wang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808162/ https://www.ncbi.nlm.nih.gov/pubmed/29467665 http://dx.doi.org/10.3389/fphys.2018.00048 |
Ejemplares similares
-
YiQiFuMai injection for chronic heart failure: Protocol for a systematic review and meta-analysis
por: Wang, Yuanping, et al.
Publicado: (2018) -
The chemical components, action mechanisms, and clinical evidences of YiQiFuMai injection in the treatment of heart failure
por: Lv, Shichao, et al.
Publicado: (2022) -
Injection of YiQiFuMai powder protects against heart failure via inhibiting p38 and ERK1/2 MAPKs activation
por: Nie, Yongwei, et al.
Publicado: (2022) -
Attenuating effect of pretreatment with Yiqifumai on lipopolysaccharide-induced intestine injury and survival rate in rat
por: Yuan, Qing, et al.
Publicado: (2011) -
YiQiFuMai Powder Injection Attenuates Coronary Artery Ligation-Induced Heart Failure Through Improving Mitochondrial Function via Regulating ROS Generation and CaMKII Signaling Pathways
por: Zhang, Yu, et al.
Publicado: (2019)